The molecular docking study was determined by the previously described procedures of Nazim et al., 2019 [30 (link)]. In this study, the selected 12 compounds were checked for interaction with particular target receptors/enzymes which were responsible for anxiolytic (potassium channel receptor, PDB: 4UUJ) [31 (link)], antidepressant (human serotonin receptor, PDB: 5I6X) [32 (link)], anti-nociceptive (cyclooxygenase-1 and 2; COX-1, PDB: 2OYE [33 (link)] and COX-2, PDB: 3HS5) [34 (link)], anti-inflammatory (Phosphodiesterase-4 inhibitor, PDB: 4WCU) [35 (link)], and thrombolytic (tissue plasminogen activator, PDB: 1A5H) [36 (link)] activities. The structures (3D) of receptors/enzymes were saved from the Protein Data Bank [37 (link)]. Molecular docking was carried out using Schrödinger Maestro (v11.1). The procedure of molecular docking study was briefly elucidated in Adnan et al., 2020 [23 (link)].
Free full text: Click here